CTMX
CytomX Therapeutics, Inc.
$3.76
-0.20 (-4.93%)
At close · Jul 10
Market Cap
$818.56M
Shares
217,702,919
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-22 | 2026-06-17 | |
| 8-K | 2026-06-03 | 2026-05-29 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-30 | 2026-06-17 | |
| 8-K | 2026-03-19 | 2026-03-17 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-13 | 2025-06-11 | |
| 8-K | 2025-05-28 | 2025-05-27 | |
| 8-K | 2025-05-13 | 2025-05-12 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-28 | 2025-06-11 | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2025-02-26 | 2025-02-24 | |
| 8-K | 2025-02-03 | 2025-01-30 | |
| 8-K | 2025-01-06 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-17 | 2024-06-12 | |
| 8-K | 2024-05-17 | 2024-05-15 | |
| 8-K | 2024-05-08 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-04 | 2024-05-15 | |
| 8-K | 2024-03-22 | 2024-03-20 | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-03-11 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-08-24 | 2023-08-08 | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-07-03 | 2023-06-29 | |
| 8-K | 2023-06-20 | 2023-06-14 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — | |
| DEF 14A | 2023-04-27 | 2023-06-14 | |
| 8-K | 2023-03-27 | — |
Showing 1–50 of 107 filings